Preben Bruun-Nyzell

Preben Bruun-Nyzell

Preben is 2N Pharma’s co-founder and CEO and brings broad business and finance experience from an international career spanning nine countries over 25 years. He is co-founder of clinical-stage vaccine company 2A Pharma, and chairman...
John Nieland, PhD

John Nieland, PhD

John is 2N Pharma’s co-founder and CSO and brings broad management experience and a strong scientific background. He was previously director of research at Medigene AG. Next, he is co-founder of the clinical-stage vaccine company 2A Pharma. In addition to...
Anne Skøttrup Mørkholt, PhD

Anne Skøttrup Mørkholt, PhD

Anne completed her doctorate at the Laboratory of Metabolism Modifying Medicine, Aalborg University. She researched the connection between dysfunction of the lipid metabolism and CNS diseases, including multiple sclerosis and depression.
Steinunn Sara Helgudóttir, PhD

Steinunn Sara Helgudóttir, PhD

Steinunn completed her doctorate at the Neurobiology Research and Drug Delivery Group at Aalborg University. She conducted research on targeted drug delivery through the blood-brain barrier.
Viktória Reháková

Viktória Reháková

Viktória successfully completed her master’s degree in Neuroscience from the University of Copenhagen. Her research primarily revolved around exploring neuronal excitability, examining structural changes in excitable domains of motoneurons, and investigating...